
Evotec Investor Relations Material
Latest events

Q2 2025
Evotec
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Evotec SE
Access all reports
Evotec SE is a biotechnology company specializing in drug discovery and development services. The company collaborates with pharmaceutical and biotech firms, academic institutions, and research organizations to identify and develop therapeutic candidates across various disease areas, including neurology, oncology, and metabolic disorders. The company is headquartered in Hamburg, Germany, and its shares are listed on the FSE (Frankfurt Stock Exchange).
Key slides for Evotec SE
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
EVT
Country
🇩🇪 Germany